The MAP2K2 Gene as Potential Diagnostic Marker in Monitoring Adalimumab Therapy of Psoriatic Arthritis

MAP kinases are some of the cascades that are specialized in the cell's response to external stimuli. Their impaired functioning can be observed during the course of psoriatic arthritis. Currently, the best-known class of biological drugs is the inhibitors of the proinflammatory cytokine TNF-α,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current pharmaceutical biotechnology Jg. 24; H. 2; S. 330
Hauptverfasser:	Krawczyk, Agata, Strzałka-Mrozik, Barbara, Juszczyk, Karol, Kimsa-Dudek, Magdalena, Wcisło-Dziadecka, Dominika, Gola, Joanna
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Netherlands 01.01.2023
Schlagworte:	Adalimumab - pharmacology Adalimumab - therapeutic use Antirheumatic Agents - adverse effects Arthritis, Psoriatic - diagnosis Arthritis, Psoriatic - drug therapy Arthritis, Psoriatic - genetics Cytokines Humans MAP Kinase Kinase 2 Tumor Necrosis Factor-alpha - genetics MAPK2 psoriatic arthritis MAPK adalimumab gene expression anti-TNF
ISSN:	1873-4316, 1873-4316
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!